Company profile: CellASIC
1.1 - Company Overview
Company description
- Provider of microfluidic platforms for live cell analysis, enabling long-term perfusion cell culture and dynamic flow control. The biotechnology company develops cutting-edge microfluidics technology to support superior live cell experiments.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CellASIC
Polyplus Transfection
HQ: France
Website
- Description: Provider of innovative solutions for in vivo, in vitro and ex vivo delivery of nucleic acids for research, bioproduction and therapeutics, including transfection reagents for lentiviral (FectoVIR®-LV) and AAV production (FectoVIR®-AAV), PEIpro® for viral vector bioproduction, in vivo–jetPEI®, LipidBrick® Library for LNP formulation, and in vivo-jetRNA®+ for mRNA/saRNA delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Polyplus Transfection company profile →
Jena Bioscience
HQ: Germany
Website
- Description: Provider of biotechnology products, including isothermal amplification and LAMP products for rapid DNA/RNA analysis, ready-to-use lyophilized PCR mixes in 96-well plates, contamination detection controls for food, cell cultures and nucleic acids, RNA/DNA preparation and cleanup kits with magnetic bead options, and click reagents for lipid and posttranslational modification analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jena Bioscience company profile →
ProtoKinetix
HQ: United States
Website
- Description: Provider of biotechnology solutions for medical researchers to enhance cell survival and health in vitro and in vivo via AAGP®, a patented anti-aging glycopeptide. Offerings include cell and organ storage, regenerative medicine (e.g., Type 1 diabetes, macular degeneration), transplant support, biomanufacturing support, and clinical research applications in ophthalmology and dermatology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProtoKinetix company profile →
Acea Biosciences
HQ: United States
Website
- Description: Provider of high-performance microelectronic systems for cell-based assays, developed and commercialized by a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acea Biosciences company profile →
Trace Genomics
HQ: United States
Website
- Description: Provider of soil health and microbiome analysis using next-generation sequencing to deliver genetic insights into soil for optimizing agricultural practices, crop yield, and sustainability. Offerings include TraceCOMPLETE (pathogen, fertility, and soil management insights), TraceCARBON (soil carbon stocks), metagenomics, hi-definition DNA and chemical soil analysis, and a farm data privacy and protection policy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trace Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CellASIC
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CellASIC
2.2 - Growth funds investing in similar companies to CellASIC
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CellASIC
4.2 - Public trading comparable groups for CellASIC
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →